Page last updated: 2024-10-26

etidronate and Scleritis

etidronate has been researched along with Scleritis in 2 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Scleritis: Refers to any inflammation of the sclera including episcleritis, a benign condition affecting only the episclera, which is generally short-lived and easily treated. Classic scleritis, on the other hand, affects deeper tissue and is characterized by higher rates of visual acuity loss and even mortality, particularly in necrotizing form. Its characteristic symptom is severe and general head pain. Scleritis has also been associated with systemic collagen disease. Etiology is unknown but is thought to involve a local immune response. Treatment is difficult and includes administration of anti-inflammatory and immunosuppressive agents such as corticosteroids. Inflammation of the sclera may also be secondary to inflammation of adjacent tissues, such as the conjunctiva.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hemmati, I1
Wade, J1
Kelsall, J1
Viñas, G1
Olivé, A1
Holgado, S1
Costa, J1

Reviews

2 reviews available for etidronate and Scleritis

ArticleYear
Risedronate-associated scleritis: a case report and review of the literature.
    Clinical rheumatology, 2012, Volume: 31, Issue:9

    Topics: Adrenal Cortex Hormones; Aged; Brain; China; Diphosphonates; Etidronic Acid; Female; Humans; Inflamm

2012
[Episcleritis secondary to risedronate].
    Medicina clinica, 2002, Apr-27, Volume: 118, Issue:15

    Topics: Calcium Channel Blockers; Etidronic Acid; Female; Humans; Middle Aged; Risedronic Acid; Scleritis

2002